Korean J Hepatobiliary Pancreat Surg.  2013 Feb;17(1):34-37. 10.14701/kjhbps.2013.17.1.34.

Primary hepatic neuroendocrine carcinoma

Affiliations
  • 1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jw.joh@samsung.com
  • 2Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • 3Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Abstract

A 67-year-old woman was admitted to our hospital under suspicion of a hepatic tumor, which had been previously diagnosed to be an adenocarcinoma by fine needle aspiration. Computed tomography and magnetic resonance imaging revealed a large tumor measuring 9 cm in diameter in Couinaud's hepatic segments 4, 5, and 8. We diagnosed the patient to have primary liver cancer, and suspected intrahepatic cholangiocarcinoma preoperatively. We performed a central hepatectomy. According to the immunohistochemical findings of the resected specimen, the tumor was diagnosed to be a primary neuroendocrine carcinoma in the liver. The patient is presently alive without recurrence at 3 months after hepatic resection.

Keyword

Liver malignancy; Hepatectomy; Neuroendocrine carcinoma; Chromogranin A

MeSH Terms

Adenocarcinoma
Biopsy, Fine-Needle
Carcinoma, Neuroendocrine
Cholangiocarcinoma
Chromogranin A
Female
Hepatectomy
Humans
Liver
Liver Neoplasms
Magnetic Resonance Imaging
Recurrence
Chromogranin A
Liver Neoplasms

Figure

  • Fig. 1 MRI scan images of a primary hepatic neuroendocrine carcinoma patient.

  • Fig. 2 Pathologic examination of primary hepatic neuroendocrine carcinoma. (A) The tumor was 10.5×10 cm size; (B) hematoxylin-eosin staining showing tumor cells (original magnification ×200); (C-E) immunohistochemical staining for CD56 (C), chromogranin A (D), and synaptophysin (E) (original magnification ×200).


Cited by  1 articles

젊은 나이에 발생하는 원발성 간 신경내분비 종양 1예
Sanghwa Song, Yangseok Koh
Korean J Gastroenterol. 2022;79(1):35-40.    doi: 10.4166/kjg.2021.139.


Reference

1. Gould VE, Jao W, Chejfec G, et al. Neuroendocrine carcinomas of the gastrointestinal tract. Semin Diagn Pathol. 1984; 1:13–18. PMID: 6400627.
2. Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol. 2003; 10:1171–1175. PMID: 14654473.
Article
3. Mima K, Beppu T, Murata A, et al. Primary neuroendocrine tumor in the liver treated by hepatectomy: report of a case. Surg Today. 2011; 41:1655–1660. PMID: 21969201.
Article
4. Pilichowska M, Kimura N, Ouchi A, et al. Primary hepatic carcinoid and neuroendocrine carcinoma: clinicopathological and immunohistochemical study of five cases. Pathol Int. 1999; 49:318–324. PMID: 10365851.
Article
5. Ishida M, Seki K, Tatsuzawa A, et al. Primary hepatic neuroendocrine carcinoma coexisting with hepatocellular carcinoma in hepatitis C liver cirrhosis: report of a case. Surg Today. 2003; 33:214–218. PMID: 12658390.
Article
6. Donadon M, Torzilli G, Palmisano A, et al. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature. Eur J Surg Oncol. 2006; 32:325–328. PMID: 16426802.
Article
7. Huang YQ, Xu F, Yang JM, et al. Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 cases. Hepatobiliary Pancreat Dis Int. 2010; 9:44–48. PMID: 20133228.
8. Hendy GN, Bevan S, Mattei MG, et al. Chromogranin A. Clin Invest Med. 1995; 18:47–65. PMID: 7768066.
Full Text Links
  • KJHBPS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr